Six months into President Donald Trump’s second term, a quick glance at the stock market might offer a reassuring picture: The S&P 500 just closed above 6,300 points for the first time ever and has ...

AstraZeneca plans a $50bn investment in US manufacturing and R&D by 2030, responding to Trump’s tariff threats and signalling ...